MLchartDataset catalogue

Allogeneic CAR T cells CT0594CP

Term · Oncology and biomedicine · MLC-T-ONC-009838

A preparation of allogeneic T lymphocytes that have been genetically modified to express chimeric antigen receptors (CARs) specific for as of yet undisclosed tumor-associated antigens (TAAs), with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic CAR T cells CT0594CP specifically targets and binds to tumor cells that express the undisclosed TAAs, resulting in tumor cell lysis.

Table 1. Record
IdentifierMLC-T-ONC-009838
FieldOncology and biomedicine
Synonymsallogeneic CAR-T cells CT0594CP
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009838",
  "term": "Allogeneic CAR T cells CT0594CP",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of allogeneic T lymphocytes that have been genetically modified to express chimeric antigen receptors (CARs) specific for as of yet undisclosed tumor-associated antigens (TAAs), with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic CAR T cells CT0594CP specifically targets and binds to tumor cells that express the undisclosed TAAs, resulting in tumor cell lysis.",
  "synonyms": [
    "allogeneic CAR-T cells CT0594CP"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/allogeneic-car-t-cells-ct0594cp/"
}

Record 724 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.